News & Events

On 4 March, investors, entrepreneurs and industry leaders will gather at Wallenberg Conference Centre, Sahlgrenska Academy, as Life Science Day marks its 10th anniversary.

In the report’s “State of the Industry” section, Emma Hallenberg, Director of Co-Ax Accelerator at Sahlgrenska Science Park, shares insights on the evolving landscape for life science innovation in Gothenburg and Sweden.

Several companies within Sahlgrenska Science Park have recently reached significant milestones, including a strategic acquisition and substantial capital secured to advance late-stage clinical trials in Europe and the United States.

Companies at CO-AX accelerator focusing on important sides of building a startups - Market, Clinical trials, Clinical studies.

VERIGRAFT AB today announce a committed capital contribution of SEK 110 million from an existing long-term shareholder.

Sightic, which develops technology to detect impairment states through the analysis of eye movements and behavioral patterns, has been acquired by Smart Eye in a deal valued at just over SEK 60 million.

CEO Cecilia Edebo will serve as a jury member at TechArena 2026.

Two companies from Sahlgrenska Science Park’s CO-AX portfolio, BrainLink Health and TrialMe, have been selected among the Top 46 startups at TECHARENA 2026.

The Life Science Barometer, initiated by SwedenBio, provides an important snapshot of the current state of the Swedish life science sector.

The new cohort brings together startups working across diagnostics, therapeutics, AI and digital health, strengthening the life science and healthtech ecosystem at Sahlgrenska Science Park.

Life science company Verigraft is this year's recipient of the Arvid Carlsson Award 2025 for its innovative technology that enables patient-tailored transplants without the need for immunosuppression.

Videm, one of Sahlgrenska Science Park’s startup companies, has for the second year in a row been selected for Ny Teknik’s prestigious 33-list.